Background. From the observations of morphology seen in early phases of the
experimental models of the irreversible mesangial proliferative glomerulon
ephritis, we hypothesized that podocyte injury is one of the important fact
ors in bringing upon irreversible glomerular alterations. To verify this hy
pothesis, we investigated whether podocyte injury induced by puromycin amin
onucleoside (PAN) injection affects the mesangial alterations of anti-Thy 1
.1 glomerulonephritis.
Methods. Female Wistar rats were injected with 0.5 mg monoclonal antibody (
mAb) 1-22-3 five days after the injection of 10 mg or 5 mg/100 g body weigh
t (BW) of puromycin aminonucleoside (PAN), and sacrificed at 7 days or 8 we
eks after the mAb 1-22-3 injection.
Results. Consecutive injections of 10 mg/100 g BW of PAN and mAb 1-22-3 cau
sed the irreversible mesangial alteration with persistent proteinuria (at w
eek 8, proteinuria 100.3 +/- 57.8 mg/24 h, matrix score 1.13 +/- 0.52, coll
agen type I score 2.04 +/- 0.53, mRNA for collagen type 1227 +/- 79% to the
group with a single injection of 1-22-3). Although single injection of 5 m
g/100 g BW of PAN was not capable of inducing abnormal proteinuria, consecu
tive injections of 5 mg/100 g BW of PAN and mAb 1-22-3 also caused irrevers
ible mesangial alteration and persistent proteinuria.
Conclusions. Podocyte injury might be an important factor that exacerbates
mesangial proliferation and mesangial matrix expansion. The irreversible me
sangial alterations caused by consecutive injections of PAN and mAb 1-22-3
may be a novel model that could be used to analyze the mechanism of progres
sive mesangial alteration.